Minaris Launches Dedicated Viral Vector Business Unit
Minaris has established a dedicated Viral Vector Business Unit to expand its contract pharmaceutical services. This new unit focuses on viral vector technologies, enhancing Minaris's capabilities in the biopharmaceutical sector and supporting advanced therapeutic development.
Contract Pharma·


